Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Annette H van der Helm-van Mil"'
Autor:
Rute B Marques, Mohamed M Thabet, Stefan J White, Jeanine J Houwing-Duistermaat, Aleida M Bakker, Gert-Jan Hendriks, Alexandra Zhernakova, Tom W Huizinga, Annette H van der Helm-van Mil, Rene E Toes
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13173 (2010)
Fc gamma receptors (FcγRs) play a crucial role in immunity by linking IgG antibody-mediated responses with cellular effector and regulatory functions. Genetic variants in these receptors have been previously identified as risk factors for several ch
Externí odkaz:
https://doaj.org/article/e0f2ba3fe0e547aa9bdf99cba5d3a9b5
Publikováno v:
RMD Open, Vol 5, Iss 1 (2019)
The therapeutic window of opportunity in rheumatoid arthritis (RA) is often referred to. However, some have questioned whether such a period, in which the disease is more susceptible to disease-modifying treatment, really exists. Observational studie
Externí odkaz:
https://doaj.org/article/1ea02921366a4e619cfb6e4dbd1a0b2c
Autor:
Pascal H P de Jong, Elise van Mulligen, Annette H van der Helm van Mil, Johanna M. W. Hazes, Angelique E. A. M. Weel, M. Kuijper
Publikováno v:
SATURDAY, 15 JUNE 2019.
Background: Previous studies have shown that it is possible to taper DMARDs in RA patients with an inactive disease, but this is accompanied with a higher chance of disease flares. Current recommendations advise to taper DMARDs from a clinical viewpo
Publikováno v:
RMD Open
RMD Open, 5(1)
RMD Open, 5(1):UNSP e000870. BMJ Publishing Group
RMD Open, 5(1)
RMD Open, 5(1):UNSP e000870. BMJ Publishing Group
The therapeutic window of opportunity in rheumatoid arthritis (RA) is often referred to. However, some have questioned whether such a period, in which the disease is more susceptible to disease-modifying treatment, really exists. Observational studie
Publikováno v:
Current Opinion in Rheumatology; May2005, Vol. 17 Issue 3, p299-304, 6p